0 results for 'Valeant Pharmaceuticals International Inc'
Actavis Buys Forest Labs for $25B
Mergers and acquisitions across the state, including a $25 billion buy for Actavis, and $425 million purchase for Valeant.Leading M&A Transactions-Target or Acquirer Based in N.J.-2013
Leading M&A transactions with the target or acquirer based in N.J. in 2013.Cold Remedy: Am Law 100 Firms Load Up on Pharma M&A
Pharmaceutical M&A got a late-year shot in the arm, with nearly $10 billion in deals involving major industry players like AstraZeneca and Bayer as 2013 came to a close. A bevy of Am Law 100 firms led by Covington, Kirkland, Sullivan & Cromwell, Skadden, and Weil have grabbed lead roles on the transactions.Valeant Buying Solta Medical for About $250M
Valeant Pharmaceuticals International Inc. is buying Solta Medical Inc. for about $250 million.Geithner Joins Warburg in Shift to Buyouts From Bailouts
As he starts his career on Wall Street next year, former Treasury Secretary Timothy Geithner has chosen a buyout firm, New York-based Warburg Pincus LLC.Four Am Law 100 Firms Advise on Valeant's $2.6 Billion Skin Care Deal
Canadian health care company Valeant Pharmaceuticals International will pay $2.6 billion to acquire Medicis Pharmaceutical Corporation in a deal that bolsters Valeant's position in the skin care products market. Sullivan & Cromwell, Skadden, Latham, and Weil Gotshal all landed roles on the transaction.Trending Stories
Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House
Brought to you by LexisNexis®
Download Now
Insights and Strategies for Effective Succession Planning in AM Law 100 Firms
Brought to you by Gallagher
Download Now
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now